ESMO Virtual Summit Russia 2021 (10-11 June 2021, Moscow, Russia)

ESMO Virtual Summit Russia 2021

10-11 June 2021


Summit Co-Chairs

  • Karin Jordan, Germany
  • Alexey Tryakin, Russia

Faculty

  • Jean-Pascal Machiels, Belgium
  • Svetlana Kutukova, Russia
  • Ilya Romanov, Russia
  • Pierre Blanchard, France
  • Amanda Psyrri, Greece
  • Chiara Cremolini, Italy
  • Mark Saunders, United Kingdom
  • Miriam Koopman, Netherlands
  • Ivan Rykov, Russia
  • Karin Jordan, Germany
  • Alexey Tryakin, Russia
  • Mikhail Fedyanin, Russia
  • Alexander Fedenko, Russia
  • Silvia Stacchiotti, Italy
  • Paolo Dei Tos, Italy
  • Robin Jones, United Kingdom
  • Jean-Yves Blay, France
  • Silvie Bonvalot, France
  • Giuseppe Curigliano, Italy
  • Timur Mitin, United States
  • Mona Frolova, Russia
  • Nadia Harbeck, Germany
  • Alexander Petrovsky, Russia

Learning Objectives

  • To provide the oncology community with a summary of the most significant treatment advances presented at the ESMO Congresses
  • To learn how to best sequence or combine therapies in different tumor types
  • To review the current standard of care and emerging therapeutic strategies for key malignancies from a local and international perspective
  • To discuss the current controversies in the management of specific cancers

Accreditation

The programme of this event will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further information please refer to ESMO-MORA Recertification Process & Requirements.


PROGRAMME

Thursday, June 10th 2021 (Central European Summer Time)

09:50-10:00 – Welcome & Introduction
Welcome from RUSSCO and ESMO


SESSION 1. Head and Neck Carcinoma

Chairs: Jean-Pascal Machiels, BE and Ilya Romanov, RU

10:00-10:20 – Advances of 2020-2021 in the locoregional treatment
Jean-Pascal Machiels, BE
10:20-10:25 – Q&A

10:25-10:45 – Advances of 2020-2021 in metastatic disease
Svetlana Kutukova, RU
10:45-10:50 – Q&A

Treatment intensification and de-escalation. Whom and when?

10:50-11:10 – Surgeon`s perspectives
Ilya Romanov, RU

11:10-11:30 – Radiotherapist`s perspectives
Pierre Blanchard, FR

11:30-11:50 – Medical oncologist’ perspectives
Amanda Psyrri, GR

11:50-12:10 – Q&A, panel discussion

12:10-13:10 – Clinical case discussion (3x20’)
All panelists


13:10-14:40 – Virtual Lunch Break

13:30-14:30 – Satellite Symposium MSD

13:30-14:30 – Satellite Symposium Roche


SESSION 2. Colorectal carcinoma

Chairs: Ralf Hofheinz, DE and Alexey Tryakin, RU

14:40-15:05 – Practice changing studies in rectal carcinoma. Is the total neoadjuvant therapy a new standard of care?
Mark Saunders, UK
15:05-15:10 – Q&A

15:10-15:30 – Practice changing studies in metastatic disease
Miriam Koopman, NL
15:30-15:35 – Q&A

15:35-16:00 – Rectal carcinoma with liver metastases. How to choose the correct route?
Chiara Cremolini, IT
16:00-16:05 – Q&A

Third line of treatment. Is therapy reinduction a preferred option for the majority of patients?

16:05-16:20 – Pro
Alexey Tryakin, RU

16:20-16:35 – Contra
Ivan Rykov, RU

16:35-16:40 – Q&A

16:40-17:00 – Molecular driven treatment in later lines
Mikhail Fedyanin, RU
17:00-17:05 – Q&A

17:05-18:05 – Clinical case discussion (3x20’)
All panelists


18:15-19:35 – Satellite Symposium AstraZeneca

18:15-19:35 – Satellite Symposium BMS


Note: Each 20-minute slot for clinical case discussion includes 15’ case presentation and 5’ Q&A/panel discussion.


Friday, June 11th 2021 (Central European Summer Time)

SESSION 3. Sarcoma and GIST

Chairs: Fedenko Alexander, RU and Silvia Stacchiotti, IT

09:00-09:25 – Practice changing studies in sarcoma and GIST
Silvia Stacchiotti, IT
09:25-09:30 – Q&A

09:30-09:50 – Diagnostic pathology in soft tissue sarcoma. What clinicians have to know?
Paolo Dei Tos, IT
09:50-09:55 – Q&A

09:55-10:20 – Chemotherapy of localized and advanced soft tissue sarcoma. Is there a room for personalized treatment?
Robin Jones, UK
10:20-10:25 – Q&A

10:25-10:50 – Pediatric sarcoma in adults
Jean-Yves Blay, FR
10:50-10:55 – Q&A

10:55-11:20 – Treatment options of retroperitoneal sarcoma after the STRASS study results
Silvie Bonvalot, FR
11:20-11:25 – Q&A

11:25-12:25 – Clinical case discussion (3x20’)
All panelists


12:35-13:35 – Virtual Lunch Break

12:35-13:35 – Satellite Symposium Roche

12:35-13:35 – Satellite Symposium Pfizer


SESSION 4. Breast carcinoma

Chairs: Giuseppe Curigliano, IT, Timur Mitin, USA, Mona Frolova, RU

13:50-14:15 – Practice changing studies in early stages
Nadia Harbeck, DE
14:15-14:20 – Q&A

14:20-14:45 – Practice changing studies in metastatic disease
Giuseppe Curigliano, IT
14:45-14:50 – Q&A

Treatment intensification and de-escalation in nonmetastatic disease. Whom and when?

14:50-15:10 – Surgeon`s perspectives
Alexander Petrovsky, RU

15:10-15:30 – Radiotherapist`s perspectives
Timur Mitin, USA

15:30-15:50 – Medical oncologist’ perspectives
Mona Frolova, RU

15:50-16:10 – Q&A, panel discussion

16:10-17:10 – Clinical case discussion (3x20’)
All panelists


17:10-17:20 – Adjourn and Closing Remarks


Note: Each 20-minute slot for clinical case discussion includes 15’ case presentation and 5’ Q&A/panel discussion.



Registration

Registration is free of charge.

* Required fields

First and Last name *

Year of birth *

Specialization *

Place of work *

Job position *

E-mail *

Country *

City *

Address *

Tel *

Refresh Listen

image Code:



registration »


Уважаемые пользователи!
Регистрируясь на сайте, вы подтверждаете свое согласие на получение информационной рассылки по указанному электронному адресу.
В случае успешной регистрации на указанный вами адрес электронной почты будет выслано письмо с подтверждением. Если вы не получили подтверждающее письмо в пределах 24 часов с момента регистрации, то проверьте папку «спам», повторите регистрацию (возможно, вы указали неправильный адрес электронной почты) или свяжитесь с нами по электронной почте